Lexicon Pharmaceuticals(LXRX) - 2023 Q4 - Annual Report
Lexicon Pharmaceuticals(LXRX)2024-03-25 20:00| UNITED | STATES | | | --- | --- | --- | | SECURITIES AND EXCHANGE | | COMMISSION | | Washington, D.C. 20549 | | | | FORM | 10-K | | | (Mark One) | | | | ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT | | | | OF 1934 | | | | For the Fiscal Year Ended December 31, 2023 | | | | or | | | | ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT | | | | OF 1934 | | | | For the Transition Period from _____________ to _____________ | | | | Commission Fil ...